Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogen therapy may help treat hidradenitis suppurativa.

Androstenedione, a hormone supplement, doesn't improve muscle or performance and can cause harmful side effects.

Swimming in Lake Malawi can lead to schistosomiasis, hepatitis B vaccine might cause temporary hair loss, and certain drinks affect kidney stone risk.

Anti-IL-1 treatments might help with certain types of hair loss in people with high inflammation.

Blocking IL-1 could help treat some hair loss conditions; alopecia affects liver detox systems; spironolactone is better than finasteride for female hair growth; focusing on the catagen hair phase could lead to new alopecia treatments.

Spironolactone is more effective than finasteride in treating excessive hair growth in women.

The book is a valuable reference on androgenic disorders for professionals but not suitable for laypeople or medical students.

PCOS is a hormonal issue in women that is usually treated with birth control pills, metformin, and lifestyle changes, with early treatment helping to reduce complications and improve life quality.

Early treatment of Female Pattern Hair Loss is important to stop it from getting worse, and various treatments can help, especially in mild to moderate cases.

Combining topical dutasteride with microneedling is more effective for hair growth than microneedling alone.

New treatment improves male hair loss.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Hair follicle biology advancements may lead to better hair growth disorder treatments.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

VEGF helps hair grow and determines follicle size by increasing blood vessel growth.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

The document concludes that non-binary individuals need compassionate support and recognition in healthcare, without being pathologized.

Rosacea is a skin condition with unclear causes, classified into four subtypes.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.